CompositionJalra-M 50mg/500mg Tablet is a combination medicine used to manage blood sugar levels in adults with type 2 diabetes mellitus when single-drug therapy, diet, and exercise are insufficient. Controlling blood sugar effectively helps lower the long-term risk of serious complications such as kidney damage, nerve problems, eye damage, and cardiovascular issues.
It combines vildagliptin, a DPP-4 inhibitor that stimulates insulin release from the pancreas after meals, and metformin, a biguanide that improves insulin sensitivity and decreases glucose production in the liver. Take it with or immediately after food as prescribed to ensure optimal absorption and reduce stomach discomfort. Continue taking it regularly even if your blood sugar levels stabilise, and do not stop taking it suddenly without consulting your doctor.
Adopting medicine-specific lifestyle practices is essential alongside medication. Maintain a balanced diet with controlled carbohydrate and sugar intake, engage in regular physical activity, monitor your blood glucose levels routinely, keep a healthy body weight, and avoid excessive alcohol intake.
Before taking this medicine, inform your doctor if you have any history of kidney disease, liver impairment, heart failure, or severe infection. Regular liver function tests and kidney monitoring are recommended during treatment. Discontinue treatment and seek medical advice immediately if you experience persistent severe abdominal pain, persistent nausea, or yellowing of the skin or eyes.
